Ralph Izzo

October 17, 2026

Ovintiv receives multiple analyst price target raises. Several research houses kept overweight or outperform ratings on Ovintiv and lifted their price targets, with Morgan Stanley moving to $71, Wells Fargo to $82, RBC to $90 and Truist to $77. The upgrades cite strong free‑cash‑flow generation from the company's Permian assets and the benefit of higher crude prices. The consensus analyst target is now about $78, above the current trading range.

October 17, 2026

CMS Energy price target lowered to $77 as earnings approach. Truist Securities kept its positive view on CMS Energy but cut its price target to $77. Analysts are also looking ahead to the company's next earnings report, expecting details on utility performance and revenue trends. The combination of a revised target and upcoming earnings makes the news relevant for investors watching the stock.

October 17, 2026

BNY Q3 Earnings Show Margin Gains and Raised Outlook. Bank of New York Mellon reported third-quarter results that highlighted margin improvements and a raised outlook, with a focus on AI initiatives. While the market reaction was muted, analysts noted the earnings beat. One firm maintained its stance but lowered its price target to $165, reflecting a cautious view despite the positive fundamentals.

October 17, 2026

PSEG Q3 Earnings Due Nov 2; Truist Cuts Target to $78. Public Service Enterprise Group is set to report its third-quarter financial results on November 2. Ahead of this release, Truist Securities maintained a Hold rating but lowered its price target to $78. The company also published its 2026 Sustainability Report, highlighting ongoing efforts in reliability and community support.